Cancer
The Delhi State Cancer Institute has begun training doctors and nursing officers from various hospitals in the city to provide chemotherapy services at District Day Care Cancer Centres (DCCCs). This initiative is part of the government's plan to set up day-care centers for cancer treatment at all district
Cancer
Scientists from the Wellcome Sanger Institute, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH), and their collaborators have conducted a systematic study of the genetic effects of chemotherapy on healthy tissues, specifically on blood cell genomes. The research, published in Nature Genetics, reveals that many, but not
Cancer
Researchers at the University of Texas MD Anderson Cancer Center have made a breakthrough in understanding the optimal time point for monitoring human papillomavirus (HPV) circulating tumor DNA (ctDNA) as a prognostic biomarker for localized anal cancer. According to the study, detecting HPV ctDNA three months after chemoradiation is associated
Cancer
Palliative care for cancer patients often relies on parenteral opioid administration, but the optimal route remains uncertain. A recent study aimed to compare the effectiveness and safety of subcutaneous (SC) versus intravenous (IV) infusion with bolus doses of morphine in a randomized controlled trial. The study involved 60 hospitalised palliative
Cancer
Researchers at Zhejiang University have made significant breakthroughs in developing a non-invasive, convenient, and rapid method for gastric cancer screening using a deep learning algorithm with Robust Tabular AutoEncoder Interpolator (RTAEI). The study, published in IEEE Transactions on Consumer Electronics, highlights the potential of AI in healthcare and the challenges
Cancer
Research from Titu Maiorescu University in Romania has found that patients with cancer and severe COVID-19 pneumonia treated with azithromycin and anakinra frequently develop dysglycemia, necessitating initiation of sulfonylurea therapy. The study retrospectively reviewed adults with diabetes and cancer who were hospitalized for COVID-19 between March 2020 and August 2022.
Cancer
The HER2 Positive Gastric Cancer pipeline landscape exhibits a robust space with 20+ active players working to develop 20+ pipeline therapies for HER2 Positive Gastric Cancer treatment. AstraZeneca and Daiichi Sankyo are among the leading companies driving innovation in the therapeutics segment with their respective pipeline drugs. The pipeline report
Cancer
A team of researchers from Wuhan University has published a study in the IEEE Journal of Biomedical and Health Informatics, showcasing a novel method for prioritizing personalized cancer driver genes based on higher-order interactions among genes. This breakthrough approach, known as PITCH, has the potential to revolutionize cancer therapy by
Cancer
The Homi Bhabha Cancer Hospital and Research Centre in Punjab has introduced DNA and RNA-based Next Generation Sequencing (NGS) for advanced cancer diagnosis and personalized treatment in its Mohali unit. This technology enables rapid and comprehensive analysis of genetic mutations driving cancer, allowing doctors to tailor treatment plans to a
Cancer
Researchers at Tzu Chi University have discovered that simvastatin, a commonly used medication for cholesterol management, may have a repurposed role in cancer therapy, specifically in treating endometrial cancer. The study investigated the effects of simvastatin on endometrial cancer-associated mesenchymal stem cells (EmCaMSCs), which play a crucial role in immunosuppression
Cancer
According to a recent study published in Cancer Epidemiology, aspirin may play a role in reducing the risk of gastric cancer, but the dose-response relationship between aspirin use and gastric cancer risk remains unclear. The systematic review and meta-analysis analyzed data from cohort studies published between 2014 and 2024, involving
Cancer
A new study on endometrial cancer has found significant differences in the efficacy and safety of atezolizumab between Asian and non-Asian patients. The research analyzed data from the AtTEnd trial, a phase III double-blind randomized placebo-controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent
